Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Compassion use trial of PN 27.1 in prostate cancer patients underway

May 10, 1996

Hybridon will file IND for antisense PKA down-regulator

May 10, 1996

SunPharm to test DEHOP in cancer patients

May 10, 1996

Oncolysin B effective in tumor models in mice; phase II trials underway

May 10, 1996

Agouron reports phase II data for Thymitaq

May 3, 1996

Hybridon reports oligonucleotide MDR inhibitors

May 3, 1996

Vertex dedicates significant efforts to MDR-reversing agents

May 3, 1996

Receptagen will develop vitamin B12 uptake inhibitors

May 3, 1996

Somatix receives patent protection for novel glioma treatment

May 3, 1996

NSAID blocks carcinogenesis in rodent models

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...